Acute lymphoblastic leukaemia (ALL) is the commonest form of childhood malignancy with
an estimated annual incidence of 40 to 50 new cases (< 15 years) in Hong Kong. The cure …

The cure rate of acute lymphoblastic leukemia (ALL) in children dramatically improved over
past 5 decades from zero to about 80%. The main cause of improvement is owing to the …

This multicenter study used the Shanghai Children's Medical Center (SCMC)‐ALL‐2005
protocol for treatment of young patients (< 2 years old) with acute lymphoblastic leukaemia …

Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood and has
served as a model system for clinical and basic research beyond pediatric hemato-oncology …

The development of effective therapy for children with acute lymphoblastic leukemia is one
of the great successes of clinical hematology andoncology. Fifty years ago, childhood acute …

Abstract Background The Chinese population is the biggest ethnic group in the world.
However, there are few reports on the treatment outcome of childhood acute lymphoblastic …

Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood,
accounting for almost 30% of pediatric cancers. Despite the high rate of cure, ALL is one of …

Acute lymphoblastic leukemia (ALL) is the most common hematological cancer in children.
The survival rates have improved significantly in recent decades, and the current therapy …

Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood with a
peak incidence between 2 and 6 years of age. Recent advances in understanding the …

Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, affecting
approximately 2900 children and adolescents in the United States each year (Ries et al …